Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma

By Stauder Michael C.   Miller Robert C.  

Cancers, Vol. 2, Iss. 3, 2010-08 ,pp. : 1565-1575

MDPI

Access to resources Recommend Favorite

Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 156-161

Karger

Access to resources Recommend Favorite

Phase II Study of Biweekly Plitidepsin as Second-Line Therapy for Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

By Dumez Herlinde   Gallardo Enrique   Culine Stephane   Galceran Joan Carles   Schöffski Patrick   Droz Jean P.   Extremera Sonia   Szyldergemajn Sergio   Fléchon Aude  

Marine Drugs, Vol. 7, Iss. 3, 2009-09 ,pp. : 451-463

MDPI

Access to resources Recommend Favorite

Dosimetry-Based Consideration on Remission and Relapse after Therapy with ²²³Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case Report

By Mangano Anna Maria   Pacilio Massimiliano   Ialongo Pasquale   Semprebene Alessandro   Ventroni Guido   Mango Lucio  

Diagnostics, Vol. 8, Iss. 1, 2018-02 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite

Minimal Residual Disease as a Predictive Factor for Relapse after Allogeneic Hematopoietic Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia in First and Second Complete Remission

By Grubovikj Rada M.   Alavi Asif   Koppel Ahrin   Territo Mary   Schiller Gary J.  

Cancers, Vol. 4, Iss. 2, 2012-06 ,pp. : 601-617

MDPI

Access to resources Recommend Favorite